News brief
On 2026/9/24, AIUnderstanding reported that Biolevate had raised EUR 30 million in Series A funding. It focuses on biotechnology and drug R&D.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- aiunderstanding.org ↗Published Sep 24, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月24日，据AIUnderstanding报道，Biolevate完成3000万欧元A轮融资。公司聚焦生物技术与药物研发。